Table 2.
Sociodemographic and Baseline Clinical Data of the Total Sample and by Cannabis Use Group
| Total (n=92) | Never Used (n = 40) | Continued to Use (n = 25) | Used and Stopped (n = 27) | P Value | |
| Gender | |||||
| Female | 45 (48.9%) | 21 (52.5%) | 12 (48%) | 12 (44.4%) | χ2 = 0.43 (P = .807) |
| Male | 47 (51.1%) | 19 (47.5%) | 13 (52%) | 15 (55.6%) | |
| Age, y | 29.78 ± 10.77 | 35.43 ± 12.59 | 26.00 ± 5.99 | 24.93 ± 6.91 | F = 12.17 (P < .001) |
| Civil status | |||||
| Married | 16 (17.4%) | 12 (30%) | 1 (4%) | 3 (11.1%) | χ2 = 8.28 (P = .016) |
| Other | 76 (82.6%) | 28 (70%) | 24 (96%) | 24 (88.9%) | |
| Residency | |||||
| With relatives | 69 (75%) | 31 (77.5%) | 19 (76%) | 19 (70.4%) | Fisher (P = .29) |
| Alone | 8 (8.7%) | 4 (10%) | 0 (0%) | 4 (14.8%) | |
| Other | 15 (16.3%) | 5 (12.5%) | 6 (24%) | 4 (14.8%) | |
| Philips | 5.63 ± 3.01 | 5.60 ± 3.70 | 6.04 ± 2.30 | 5.30 ± 2.45 | F = 0.39 (P = .67) |
| PANSS positive | 24.76 ± 6.86 | 23.63 ± 6.88 | 25.44 ± 6.96 | 25.81 ± 6.74 | F = 0.99 (P = .37) |
| PANSS negative | 18.88 ± 9.39 | 19.13 ± 10.00 | 16.96 ± 9.06 | 20.30 ± 8.79 | F = 0.84 (P = .43) |
| GAF | 55.18 ± 13.17 | 56.13 ± 13.50 | 55.08 ± 14.04 | 53.89 ± 12.18 | F = 0.23 (P = .79) |
| Alcohol abuse | 49 (53.3%) | 11 (27.5%) | 19 (76%) | 19 (70.4%) | Fisher (P < .001) |
| Drugs | 30 (32.6%) | 3 (7.5%) | 16 (64%) | 11 (40.7%) | Fisher (P < .001) |
Note: PANSS, Positive and Negative Symptoms Scale; GAF, Global Assessment of Functioning.